Effect of bradykinin, TGF-β1, IL-1β, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 283, Issue 4 27-4, 2002, Pages

  Bradbury, D A ^a   Newton, R ^b   Zhu, Y M ^a   Stocks, J ^a   Corbett, L ^a   Holland, E D ^a   Pang, L H ^a   Knox, A J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cell culture; Human; Prostaglandin E2

Indexed keywords

BRADYKININ; CYCLOHEXIMIDE; DEXAMETHASONE; INDOMETACIN; INTERLEUKIN 1BETA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTANOID; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; CELL VIABILITY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; INHIBITION KINETICS; LUNG CIRCULATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PULMONARY ARTERY; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

EID: 0036784371     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00070.2002     Document Type: Article

References (48)

1. Extracorporeal circulation does not induce intra-alveolar release of endothelin 1, but only a modest overproduction in pulmonary circulation
2. 2 by bovine cultured airway smooth muscle cells: Regulation by cAMP
3. Cyclooxygenase-2 in vascular smooth muscle
4. Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: Role of endogenous prostanoids
5. Role of transforming growth factor-β in human disease
6. Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-β
7. Effects of acute and chronic hypoxia on rat lung cyclooxygenase
8. Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery
9. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation
10. 2 by bovine cultured airway smooth muscle cells and its inhibition by cyclooxygenase inhibitors
11. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
12. Differences in prostaglandin metabolism in cultured aortic and pulmonary arterial endothelial cells exposed to acute and chronic hypoxia
13. 2 release in human airway smooth muscle cells
14. Primary pulmonary hypertension
15. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension
16. Cell cycle-dependent expression of cyclooxygenase- 2 in human fibroblasts
17. Synergy between cyclooxygenase-2 induction and arachidonic acid supply in vivo: Consequences for nonsteroidal anti-inflammatory drug efficacy
18. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension
19. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
20. 2 production in human isolated pulmonary artery smooth muscle cells: Concomitant and differential release
21. Autocrine function of inducible nitric oxide synthase and cyclooxygenase-2 in proliferation of human and rat pulmonary artery smooth muscle cells: Species variation
22. Hypoxic conditions restore lost sensitivity to the growth inhibitory effect of transforming growth factor-β1 (TGF-β1) in proliferating rat hepatocytes in vitro
23. Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension
24. Pulmonary hypertension in POEMS syndrome: A new feature mediated by cytokines
25. Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs
26. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition
27. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
28. 1 receptors and the cardiovascular system: Regulation of expression and function
29. Metabolism of bradykinin in vivo in humans: Identification of BK-(1-5) as a stable plasma peptide metabolite
30. Quantification of BK-(1-5), the stable bradykinin plasma metabolite in humans, by a highly accurate liquid-chromatographic tandem mass spectrometric assay
31. Bradykinin stimulates NF-κB activation and interleukin-1β gene expression in cultured human fibroblasts
32. Impaired cAMP production in human airway smooth muscle cells by bradykinin: Role of cyclooxygenase products
33. Role of cyclooxygenase-2 induction in interleukin-1β induced attenuation of cultured human airway smooth muscle cell cyclic AMP generation in response to isoprenaline
34. Effect of interleukin-1β, tumour necrosis factor-α and interferon-γ on the induction of cyclooxygenase-2 in cultured human airway smooth muscle cells
35. 2 release by bradykinin in human airway smooth muscle cells: Involvement of cyclooxygenase-2 induction
36. Transforming growth factor-β1 in asthma. Measurement in bronchoalveolar lavage fluid
37. Down-regulation of cytokine-induced cyclooxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation
38. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity
39. Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression
40. Hypoxia induces cyclooxygenase-2 via the NF-κB p 65 transcription factor in human vascular endothelial cells
41. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
42. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family
43. Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension
44. Hypoxia-induced pulmonary vascular remodeling: A model for what human disease?
45. 2 by cultured human pulmonary artery smooth muscle cells
46. Eicosanoid profile in cultured human pulmonary artery smooth muscle cells treated with IL-1β and TNF-α
47. Characterization of human cyclooxygenase 2 gene promoter localization of a TGF-β response element
48. Proof without prejudice: Use of the KolmogorovSmirnov test for the analysis of histograms from flow systems and other sources